Case study · Life sciences

Global M&A technical authority,
S&P 100 industrial & life sciences group.

Primary technical decision-maker for global M&A inside an S&P 100 group with a long record of acquisitions and separations — delivering fast, objective, evidence-based reads on targets before the price was set.

GlobalM&A technical authority
S&P 100Industrial & life sciences group
AutomatedCodebase scanning

Delivered by ICAN’s leadership in prior engagements and senior roles.

The challenge

Price the technology before you sign for it.

Inside a group of S&P 100 scale, acquisitions arrive continuously — and every deal is priced on what can be seen. The technology risks that actually destroy value live elsewhere: unreviewed code, undocumented dependencies, open-source licence exposure and disaster-recovery gaps no data room will show you.

The role: serve as the primary technical decision-maker for global M&A — the single technical authority whose read on a target reached the deal team before the price was set.

What was actually done

Evidence, not questionnaires.

Automated codebase scans

Every target's codebase scanned automatically — objective, comparable coverage of the whole estate, with no reliance on the target's self-assessment or cherry-picked demos.

DevSecOps assessment

The target's security and delivery posture read from how it actually builds and ships — vulnerability exposure and engineering maturity, scored on evidence.

Cloud-readiness scoring

Each estate scored for what integration would actually cost — how far the technology was from where the deal model assumed it already was.

Open-source & DR exposure

Licence obligations that can poison proprietary claims, and disaster-recovery practices tested against what the paperwork promised.

Fast, objective, evidence-based reads before the price was set — a risk profile the deal team could price, not a hedge-everything memo.
What it demonstrates

We’ve run the function our clients are trying to staff.

Serving as primary technical authority for global M&A inside a company of S&P 100 scale is not advisory experience — it is the buy-side technology function itself, run from the inside, across a long record of acquisitions and separations. That is the seat ICAN's M&A advisory clients are trying to fill when a deal lands on their desk.

Before you sign

Assessing a target?

Tell us about the deal. We'll come back with a clear, evidence-based view of the technology risk — before the price is set, not after.